Abstract
Purpose The pandemic of Covid-19 has caused tremendous losses to lives and economy in the entire world. The machine learning models have been applied to the radiological images of the Covid-19 positive patients for disease prediction and severity assessment. However, a segmentation model for detecting the opacity regions like haziness, ground-glass opacity and lung consolidation from the Covid-19 positive chest X-rays is still lacking.
Methods The recently published collection of the radiological images for a rural population in United States had made the development of such a model a possibility, for the high quality images and consistent clinical measurements. We manually annotated 221 chest X-ray images with the lung fields and the opacity regions and trained a segmentation model for the opacity region using the Unet framework and the Resnet18 backbone. In addition, we applied the percentage of the opacity region over the area of the total lung fields for predicting the severity of patients.
Results The model has a good performance regarding the overlap between the predicted and the manually labelled opacity regions. The performance is comparable for both the testing data set and the validation data set which comes from very diverse sources. However, careful manual examinations by experienced radiologists show mistakes in the predictions, which could be caused by the anatomical complexities. Nevertheless, the percentage of the opacity region can predict the severity of the patients well in regards to the ICU admissions and mortality.
Conclusion In view of the above, our model is a successful first try in the development of a segmentation model for the opacity regions for the Covid-19 positive chest X-rays. However, additional work is needed before a robust model can be developed for the ultimate goal of the implementations in the clinical setting.
Model and supporting materials can be found in https://github.com/haimingt/opacity_segmentation_covid_chest_X_ray.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was not funded.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not Applicable
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail: ningzhithm{at}gmail.com
E-mail: sun{at}uhcl.edu
E-mail: YiLiMD{at}gmail.com
E-mail: leonardoxia{at}gmail.com
Data Availability
The model, manual segmentation and other supporting materials can be found in https://github.com/haimingt/opacity_segmentation_covid_chest_X_ray.
https://github.com/haimingt/opacity_segmentation_covid_chest_X_ray
